Credit: Gorodenkoff Productions OU/Adobe Stock
Obesity shots like Wegovy are already a cultural phenomenon. Now it's looking like pill forms of the drugs from Eli Lilly & Co. and Novo Nordisk A/S are just as good at helping people lose weight, setting the stage for even more explosive growth in the years ahead.
Novo and Lilly's experimental obesity pills helped people lose about 15% of body weight, similar to weight-loss shots on the market already, according to findings presented at the American Diabetes Association's conference over the weekend. Meanwhile, Pfizer Inc. said it will discontinue one of its weight loss pills under development as safety concerns arose.
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2025 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
